AI Terminal

MODULE: AI_ANALYST
Interactive Q&A, Risk Assessment, Summarization
MODULE: DATA_EXTRACT
Excel Export, XBRL Parsing, Table Digitization
MODULE: PEER_COMP
Sector Benchmarking, Sentiment Analysis
SYSTEM ACCESS LOCKED
Authenticate / Register Log In

The Israel Land Development Company Ltd.

Share Issue/Capital Change Nov 8, 2019

6886_rns_2019-11-08_cd5fa28d-54cc-41ef-b176-23ff25662db6.html

Share Issue/Capital Change

Open in Viewer

Opens in native device viewer

National Storage Mechanism | Additional information

You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.

RNS Number : 7944S

Oil and Gas Development Company Ltd

08 November 2019

No. CS04-08 (PSX/LSE/SECP)

November 08, 2019

1. The General Manager,

Pakistan Stock Exchange Limited,

Stock Exchange Building,

Stock Exchange Road,

Karachi-74000, Pakistan.
2. London Stock Exchange Plc.,

10 Paternoster Square,

London EC4M 7LS.

Tel: (44) 20 7334 8907

Subject:        MATERIAL INFORMATION -ISSUANCE OF BONUS SHARES BY MARI PETROLEUM COMPANY LIMITED

Dear Sir,

In accordance with Section 96 of the Securities Act, 2015 and Clause 5.6.1(a) of PSX Regulations, this is informed that shareholders of Mari Petroleum Company Limited (MPCL) in their 35th Annual General Meeting (AGM) held on October 22, 2019 have approved allotment of 10% bonus shares for every ten shares held (i.e 10%).

2.       Therefore the present number of shares of MPCL held by Oil and Gas Development Company Limited (OGDCL) has increased from 24,052,875 shares to 26,458,162 shares after addition of recently issued 2,405,287 bonus shares.

Yours Sincerely,

(Ahmed Hayat Lak)

Company Secretary

Copy:

Director/HOD,

Surveillance, Supervision and Enforcement Department

Securities & Exchange Commission of Pakistan,

NIC Building, 63 Jinnah Avenue, Blue Area,

Islamabad

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

END

MSCBPBMTMBMMBTL

Talk to a Data Expert

Have a question? We'll get back to you promptly.